| Acusensus Limited (ACE) ORDINARY FULLY PAID |
Information Technology |
$188 |
Application for quotation of securities - ACE
|
11 Jun 2026 8:39AM |
$1.235 |
$1.110 |
fallen by
10.12%
|
|
| West Cobar Metals Limited (WC1) ORDINARY FULLY PAID |
Materials |
$6 |
Proposed issue of securities - WC1
|
11 Jun 2026 8:39AM |
$0.020 |
$0.014 |
fallen by
30%
|
|
| West Cobar Metals Limited (WC1) ORDINARY FULLY PAID |
Materials |
$6 |
Proposed issue of securities - WC1
|
11 Jun 2026 8:39AM |
$0.020 |
$0.014 |
fallen by
30%
|
|
| West Cobar Metals Limited (WC1) ORDINARY FULLY PAID |
Materials |
$6 |
Acquisition of Nevada Fluorspar Project and Placement
|
11 Jun 2026 8:39AM |
$0.020 |
$0.014 |
fallen by
30%
|
|
WC1 - Price-sensitive ASX Announcement
Full Release
Key Points
- WC1 acquires 100% interest in Baxter Fluorspar Project in Nevada.
- The project historically produced high-grade fluorspar from 1928 to 1957.
- Fluorspar is a critical mineral for multiple high-tech industries.
- The acquisition includes a 30-day due diligence period.
- WC1 raises over $1 million through a share placement.
- Funds to be used for due diligence and exploration at Baxter and other projects.
- The acquisition enhances WC1's critical minerals strategy with US market exposure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$93 |
LTR Secures Exclusive U.S. Pharmacy Partner for ROXUS
|
11 Jun 2026 8:38AM |
$0.425 |
$0.510 |
risen by
20%
|
|
LTP - Price-sensitive ASX Announcement
Full Release
Key Points
- Binding term sheet with Strive Specialties Inc. for exclusive US pharmacy fulfillment rights for ROXUS®.
- Represents a key milestone in LTR Pharma's US commercialization strategy.
- ROXUS® to be distributed via a multi-channel strategy including telehealth.
- LTR Pharma holds product ownership and supply rights.
- Strive Pharmacy provides the fulfillment infrastructure.
- Agreement includes exclusivity, confidentiality, and service-level provisions.
- Two-year initial term with annual auto-renewal.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pioneer Credit Limited (PNC) ORDINARY FULLY PAID |
Financials |
$112 |
Change of Director's Interest Notice - KR John
|
11 Jun 2026 8:38AM |
$0.650 |
$0.695 |
risen by
6.92%
|
|
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$4,914 |
Update - Notification of buy-back - AMP
|
11 Jun 2026 8:37AM |
$1.535 |
$2.020 |
risen by
31.60%
|
|
| Viking Mines Limited (VKA) ORDINARY FULLY PAID |
Materials |
$24 |
GOLD COAST INVESTMENT SHOWCASE PRESENTATION
|
11 Jun 2026 8:36AM |
$0.011 |
$0.010 |
fallen by
9.09%
|
|
| hipages Group Holdings Limited (HPG) ORDINARY FULLY PAID |
Communication Services |
$100 |
Update - Notification of buy-back - HPG
|
11 Jun 2026 8:35AM |
$0.720 |
$0.730 |
risen by
1.39%
|
|
| L1 Global Long Short Fund Limited (GLS) ORDINARY FULLY PAID |
Financials |
$1,117 |
Weekly Net Tangible Asset Backing
|
11 Jun 2026 8:34AM |
$1.775 |
$2.040 |
risen by
14.93%
|
|
| Energy One Limited (EOL) ORDINARY FULLY PAID |
Information Technology |
$352 |
Resignation & Recruitment of CFO
|
11 Jun 2026 8:34AM |
$12.980 |
$11.080 |
fallen by
14.64%
|
|
| IDP Education Limited (IEL) ORDINARY FULLY PAID |
Consumer Discretionary |
$612 |
Change in substantial holding
|
11 Jun 2026 8:34AM |
$2.230 |
$2.200 |
fallen by
1.35%
|
|
| Argenica Therapeutics Limited (AGN) ORDINARY FULLY PAID |
Health Care |
$21 |
Investor Webinar
|
11 Jun 2026 8:33AM |
$0.110 |
$0.160 |
risen by
45.45%
|
|
| Viva Leisure Limited (VVA) ORDINARY FULLY PAID |
Consumer Discretionary |
$144 |
Update - Notification of buy-back - VVA
|
11 Jun 2026 8:33AM |
$1.555 |
$1.465 |
fallen by
5.79%
|
|
| L1 Gold Fund Limited (LGF) ORDINARY FULLY PAID |
Financials |
$948 |
Weekly Net Tangible Asset Backing
|
11 Jun 2026 8:33AM |
$1.830 |
$1.995 |
risen by
9.02%
|
|
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$64,615 |
Notice of Proposed Sale of Securities
|
11 Jun 2026 8:33AM |
$97.400 |
$114.530 |
risen by
17.59%
|
|
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$4,110 |
Update - Notification of buy-back - WGX
|
11 Jun 2026 8:33AM |
$4.520 |
$4.350 |
fallen by
3.76%
|
|
| Meteoric Resources Limited (MEI) ORDINARY FULLY PAID |
Materials |
$451 |
Caldeira Pilot Plant Delivering Exceptional Performance
|
11 Jun 2026 8:33AM |
$0.145 |
$0.155 |
risen by
6.90%
|
|
MEI - Price-sensitive ASX Announcement
Full Release
Key Points
- Caldeira Project Pilot Plant achieved 80% MREO recovery in May.
- Average MREC production recovery of 71%.
- Over 200 kg of MREC distributed for qualification and development.
- Critical rare earth elements recovery optimised, improving by 10%.
- Feedback from offtake partners is supportive, with impurities below 2%.
- Pilot Plant results exceed expectations, supporting commercial scale-up plans.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Argenica Therapeutics Limited (AGN) ORDINARY FULLY PAID |
Health Care |
$21 |
Investor Presentation
|
11 Jun 2026 8:33AM |
$0.110 |
$0.160 |
risen by
45.45%
|
|
| Argenica Therapeutics Limited (AGN) ORDINARY FULLY PAID |
Health Care |
$21 |
ARG007 (Xaranetide) Completes All Three FDA Requested Assays
|
11 Jun 2026 8:33AM |
$0.110 |
$0.160 |
risen by
45.45%
|
|
AGN - Price-sensitive ASX Announcement
Full Release
Key Points
- ARG-007 (xaranetide) completed all three FDA requested assays with favorable safety profiles.
- Successfully conducted a GLP-compliant in vitro hERG assay showing no significant inhibition of the hERG cardiac potassium channel.
- The hERG assay was the final requirement to address the FDA clinical hold for ARG-007 (xaranetide).
- Completion of the assays positions Argenica to respond to the FDA clinical hold and seek IND approval.
- Argenica aims to proceed to Phase 2b clinical trial in acute ischaemic stroke patients upon FDA approval.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ansell Limited (ANN) ORDINARY FULLY PAID |
Health Care |
$4,444 |
Update - Notification of buy-back - ANN
|
11 Jun 2026 8:33AM |
$28.960 |
$31.670 |
risen by
9.36%
|
|
| REA Group Ltd (REA) ORDINARY FULLY PAID |
Communication Services |
$21,050 |
Update - Notification of buy-back - REA
|
11 Jun 2026 8:32AM |
$149.430 |
$160.860 |
risen by
7.65%
|
|
| Southern Cross Media Group Limited (SXL) ORDINARY FULLY PAID |
Communication Services |
$259 |
FY26 Trading Update, Cost Reduction, and Accounting Matters
|
11 Jun 2026 8:32AM |
$0.590 |
$0.540 |
fallen by
8.47%
|
|
SXL - Price-sensitive ASX Announcement
Full Release
Key Points
- FY26 underlying EBITDA expected to be $185 to $190 million.
- Significant cost reduction program announced, targeting $145 to $150 million in annual run-rate benefits.
- 250 to 300 full-time equivalents to be reduced by 30 June 2026.
- Restructuring charge of around $20 million expected in FY26.
- Onerous contract provision of $65 to $70 million due to legacy TV content contract adjustments.
- Market conditions deteriorated, impacting revenue expectations.
- Reported EBITDA expected to benefit by $5 million in FY26 and $30 million in FY27 due to provisions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Goldarc Resources Limited (GA8) ORDINARY FULLY PAID |
Materials |
$42 |
Round Six Delivers Widest Intercept at Mt Stirling
|
11 Jun 2026 8:32AM |
$0.059 |
$0.060 |
risen by
1.69%
|
|
GA8 - Price-sensitive ASX Announcement
Full Release
Key Points
- GoldArc Resources Limited (ASX:GA8) is focused on exploration in Western Australia, particularly in the Leonora and Kookynie districts.
- GoldArc's Mt Stirling Project has shown significant results in their drilling programs, including high-grade gold intercepts.
- The company is conducting a 34,000m RC grade control drilling program to enhance their mine plan and production scheduling.
- Significant intercepts at Mt Stirling include 18m at 5.66 g/t gold from 1m and 29m at 2.06 g/t gold from 2m.
- The company's strategic goal is to grow its 200,000oz JORC resource base through systematic exploration.
- Mt Stirling hosts a JORC Inferred Mineral Resource of 198,000t at 2.3 g/t gold.
- Grade control drilling is used to define ore grades and boundaries for production scheduling at Mt Stirling.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Harmoney Corp Limited (HMY) ORDINARY FULLY PAID |
Financials |
$75 |
Update - Notification of buy-back - HMY
|
11 Jun 2026 8:32AM |
$0.780 |
$0.725 |
fallen by
7.05%
|
|
Call 1300 880 160
Start a chat
Schedule a call
